Navigation Links
AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate
Date:1/12/2009

akon will continue to be highly efficacious and an exceptionally high-benefit-to-cost ratio for athletes, women, baby-boomers, and seniors," added Vijay Puntambekar. "We are proud to be recognized for developing preservative-free, hard-to-formulate products. API made significant strides in addressing the specific supplement needs for active lifestyles, seniors and people with challenged immunity levels. Our core competence and aim is: Formulating Innovation," he continued.

API develops and markets preservative-free, natural products in compact dosage forms. The company was incorporated in 2005 and has in-house R&D capability and a US FDA registered manufacturing facility. The company is also launching an ultra-premium, completely natural and preservative-free cosmetic product line for the Japanese market. It will include specialty hair care and skin care beauty products. AIM Pharmakon offers diversified services in product development and project management in the areas of pharmaceuticals, natural products, consulting, and has offices in Long Island, New York, Tokyo and Mumbai.

API and Global Life Science, LLC USA- GLS have a strategic partnership in marketing, project development and project management. GLS brand products are sold in United States and offered for select African and Middle Eastern countries on an exclusivity basis. API and Global Life Science USA have an impressive array of efficacious products, including supportive dietary supplements for HIV/AIDS. Global Life Science will promote AimCa++DONAN (TM) and AimEndurance (TM), for overall cardiovascular health, globally.

###

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Push-to-Connect In-Line Filters Introduced
2. Managed Compliance Services Program (MCSP) Introduced for Small Healthcare Practitioners
3. New Stretch Mark and Skin Rejuvenation Treatment Introduced to Houston by Dr. Zaniewski-Singh
4. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
5. Groundbreaking Sign Chi Do Stress Management System Introduced by Dr. Anne Borik Now Available to the Public
6. "Campus Alert by VoiceGate" introduced at Internet Telephony(R) Conference and Expo
7. Arizona Patient Protection Act Introduced
8. Chicken pox vaccination should be introduced for children in the UK
9. New Ovarian Cancer Biomarker Research Act Introduced
10. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced
11. National CPR/AED Awareness Week Introduced in Congress

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate
AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate
(Date:11/30/2009)... Those extra helpings of gravy and dessert at the ...tline than previously thought. According to a new ...FASEB Journal ( http://www.fasebj.org ), a diet t...on genes that ultimately cause our bodies to store... a double-whammy as the already difficult task of ...
(Date:11/30/2009)...ike a pothole that worsens over time, so do knees,...NDAY, Nov. 30 (HealthDay News) -- If you,re a midd...ball court or hockey rink, take note: A new study ...st the risk of internal knee damage that could lea... injuries occurred in middle-age people who showed...
(Date:11/30/2009)..., , ENGLEWOOD, Colo., Nov. 30 /PRNewsw...nal presentation discussing what "culture of safet...day Symposium presentation, "Creating a Culture o...-system professionals discussing their experiences...culture of safety in pharmacy and the role of tech...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ -...earch report is available in its catalogue: ,, ...Opportunities ,, http://www.reportlinker.com/...s--Opportunities.html ,, Gene therapy promise...icine. Although no significant achievements for cu...
(Date:11/30/2009)...mproved screening, awareness may help delay progre... , MONDAY, Nov. 30 (HealthDay News) -- Medical...ates costs $185.5 billion a year, according to a n... billion while patients pay $36.1 billion in out-o...r female patient and $4,036 per male patient. Wome...
Breaking Medicine News(10 mins):Health News:Western diets turn on fat genes 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 4Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 5Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2
...hance health , , INDIANAPOLIS, April 30 Heartlan...ch has developed the world,s first probiotic sweet...d to boost the immune system and promote digestive...strains of influenza. , , (Photo: http://www...
... against heart attack, too , , THURSDAY, A...ed a stroke can significantly reduce the odds of a...eir blood pressure and cholesterol, new research s...niversity and Medical School in Paris. "Among them...
...are frequently exposed to potentially damaging noi...there has been little reported on their risk for n...children under the age of 18 have some hearing los...s ear, nose and throat doctors, found that 4 in 5 ...
...articipants from the medical, scientific, and busi...gress on Anti-Aging Medicine,s Spring 2009 Session...ed The American Academy of Anti-Aging Medicine (A4...s and health practitioners in 105+ countries. With...
...ion (Nasdaq: KNSY ) is scheduled to present at t...are Conference at The Palace Hotel in New York, on..., Kensey Nash,s President & CEO, will deliver ...eracast.com/webcasts/bas/healthcare09/id78208658.c...
...eaches Children the Importance of Washing their Ha...rding a potential swine flu pandemic continue to s...ed in at least ten U.S. states and eight countries...w.newscom.com/cgi-bin/prnh/20070816/DCTH039LOGO ...
Other Medicine News:Health News:Ingredient in Probiotic Sweetener Boosts Immune System 2Health News:Managing Blood Pressure, Cholesterol Cuts Stroke Risk 2Health News:Children and teenagers at risk for noise-induced hearing loss, warn America's ENT doctors 2Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 2Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 3Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 4Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 5Health News:Hand Washing Can Help Fight Against the Swine Flu 2
(Date:11/30/2009)...0 Dr. Jocelyn Rapelyea, Associate ...rge Washington University Medical Center in Washin...fied with Breast-Specific Gamma Imaging (BSGI) can... needle biopsy as well, as for pre-operative local...gical Society of North America (RSNA). ,, BSGI ...
(Date:11/30/2009)...Italy, November 30 Health Robotics...development plans and product specifications,for a... Parenteral,Nutrition", a new key component of its... Las Vegas, ASHP (Booth # 114). , "I look... the,TPNstation,s blueprints and to find out if TP...
(Date:11/30/2009)...d CHICAGO, Nov. 30 Today at the 95... Radiological Society of North America (RSNA), Bay...nrollment of the first patient in an international... and safety of florbetaben (BAY 94-9172) PET imagi... brain, which are a pathological hallmark of Alzhe...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 1Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 2Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 4Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 5Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 6Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 8Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 9Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 10Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 11Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 12Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 13Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 14Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 15Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 16Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 17Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 18AOBO Announces New Product Launch 13444 1AOBO Announces New Product Launch 13444 2AspireHR Completes Phase 1 SAP HR Initiative for Shire Pharmaceuticals 53928 1AspireHR Completes Phase 1 SAP HR Initiative for Shire Pharmaceuticals 53928 2AspireHR Completes Phase 1 SAP HR Initiative for Shire Pharmaceuticals 53928 3
...monstrates Clinical Activity, a Novel Mechanism,of...Inhibitors-, NEW HAVEN, Conn., April 16, 2007 /PRN...nc. today announced the presentation of,data valid...hillion,s NS4A antagonists, ACH-806, for the treat...2nd Annual Meeting of the,European Association for...
...(BUSINESS WIRE)--Apr 17, 2007 - GenVec, Inc.,(Nasd...sented at,the 97th annual meeting of the American ... support the use of adenovector systems,to deliver...ha)).,GenVec,s lead product candidate, TNFerade(TM...rrier, which contains the gene for,TNF(alpha), a p...
Other Medicine Technology:Achillion Presents Positive Data on Novel Mechanism for Treating,HCV at EASL Annual Meeting 2Achillion Presents Positive Data on Novel Mechanism for Treating,HCV at EASL Annual Meeting 3Achillion Presents Positive Data on Novel Mechanism for Treating,HCV at EASL Annual Meeting 4GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 2GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 3
...re highly accurate in detecting the presence of dr... by GC/MS testing. This assay provides a prelimina... (such as GC/MS) must be used in order to obtain a... applied to any drug of abuse test result, particu...
...cker version of TheraTears that is perfect for nig...tective film during the day. Because TheraTears Li...out a preservative so that unlike preserved gels, ...vative-induced irritation. And because of its pate...
...t Drops improve comfort on contact lens insertion ...s from your disinfecting system or from its bliste...place one or two drops of TheraTears on the lens r...go in much easier and much more comfortably. Then,...
...epared by coating the suture with a mixture of a c...yl lactylate. POLYSORB sutures are colored violet ...ed. POLYSORB™ sutures meet all requirements ...) and the European Pharmacopeia (EP) except for mi...
Medicine Products: